| Literature DB >> 35836434 |
Claudia Berrondo1,2, Marco Carone3, Cindy Katz4, Avi Kenny3.
Abstract
Introduction Surgical site infections (SSIs) are common and carry a significant risk of morbidity and mortality and lead to increased healthcare costs. Perioperative antibiotic prophylaxis decreases the risk of SSIs. There are several guidelines on the use of perioperative antibiotic prophylaxis. The American College of Surgeons (ACS) recommends weight-based antibiotic administration within 60 minutes prior to (two hours for vancomycin/fluoroquinolones) incision and redosing by drug half-life. There are limited data regarding adherence to existing recommendations. Furthermore, there are scarce data on the relationship between adherence to recommendations and the risk of postoperative SSI. Objectives In this study, we aimed to assess the adherence to ACS guidelines for perioperative antimicrobial prophylaxis in the Seattle Children's Hospital (SCH) National Surgical Quality Improvement Program (NSQIP) pediatric cohort and to determine whether adherence to ACS guidelines is associated with a decreased risk of SSI. the secondary objective was to identify risk factors associated with SSI in our patient population. Materials and methods We conducted a secondary analysis of an institutional NSQIP pediatric data cohort between Jan 1, 2012, and Dec 31, 2017. We calculated summary statistics to assess adherence to ACS recommendations and fit a logistic regression model to identify factors associated with the risk of SSI. Patients who did not receive antibiotic prophylaxis were excluded. Results A total of 6,072 surgeries among 5,532 patients met the inclusion criteria. Adherence was achieved for weight-based dosing in 35% of surgeries, administration prior to the incision in 91%, administration within 60 minutes (two hours for vancomycin/fluoroquinolones) in 86%, correct redosing in 97%, and to all recommendations in 29%. There were no significant associations between any adherence metrics and SSI, although confidence intervals were wide for some metrics. Factors associated with SSI when adherence was met included urgent case status, wound class 2 or 4, the American Society of Anesthesiologists (ASA) class 2-5, and surgery duration. Conclusion There was varying adherence to ACS recommendations on antibiotic prophylaxis in our cohort. More evidence is needed to better understand the effects of adherence to any or all components of the recommendations on SSI. We identified a group of pediatric patients at risk of SSI and a need for further research and targeted interventions.Entities:
Keywords: american college of surgeons; infection prevention; nsqip peds; peri-operative antibiotic prophylaxis; surgical site infection
Year: 2022 PMID: 35836434 PMCID: PMC9273524 DOI: 10.7759/cureus.25859
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Weight-based dosing and redosing intervals for antibiotic prophylaxis
| Antimicrobial | Dose | Redosing interval (hours) |
| Ampicillin-sulbactam | 50 mg/kg of the ampicillin component | 2 |
| Ampicillin | 50 mg/kg | 2 |
| Aztreonam | 30 mg/kg | 2 |
| Cefazolin | 30 mg/kg | 4 |
| Cefuroxime | 50 mg/kg | 4 |
| Cefotaxime | 50 mg/kg | 3 |
| Cefoxitin | 40 mg/kg | 2 |
| Cefotetan | 40 mg/kg | 6 |
| Ceftriaxone | 50-75 mg/kg | NA |
| Ciprofloxacin | 10 mg/kg | NA |
| Clindamycin | 10 mg/kg | 6 |
| Ertapenem | 15 mg/kg | NA |
| Fluconazole | 6 mg/kg | NA |
| Gentamicin | 2.5 mg/kg | NA |
| Levofloxacin | 10 mg/kg Neonates <1200 g 7.5 mg/kg | NA |
| Metronidazole | 15 mg/kg | NA |
| Moxifloxacin | 10 mg/kg | NA |
| Piperacillin-tazobactam | 2-9 mo 80 mg/kg of the piperacillin component >9 months and <40 kg 100 mg/kg of piperacillin component | 2 |
| Vancomycin | 15 mg/kg | NA |
Characteristics of the study population*
*Summarized at the level of surgery, the unit of analysis
Q1 – Q3: interquartile range, ACS: The American College of Surgeons
| Characteristic | Values | |
| Age, years, median (Q1 – Q3) | 7.1 (1.3 – 12.4) | |
| Sex, % (n) | Male | 54.9 (3,336) |
| Race, % (n) | American Indian or Alaska Native | 2.6 (157) |
| Asian | 8.7 (528) | |
| Black or African American | 5.1 (309) | |
| Native Hawaiian or other Pacific Islander | 1.4 (88) | |
| Unknown/not reported | 23.3 (1,412) | |
| White | 58.9 (3,578) | |
| Ethnicity, % (n) | Hispanic | 19.4 (1,179) |
| Height, cm, median (Q1 – Q3) | 115 (76 – 149) | |
| Weight, kg, median (Q1 – Q3) | 22.9 (10.2 – 44.5) | |
| Type of admission, % (n) | Inpatient | 64.5 (3,916) |
| Outpatient | 35.5 (2,156) | |
| ACS recommendation, % (n) | Correct weight-based dosing | 34.6 (2,093) |
| Administration prior to incision | 91.1 (5,530) | |
| Correct timing of administration | 85.5 (5,193) | |
| Correct redosing | 97.4 (5,913) | |
| All recommendations | 28.5 (1,726) | |
Association between adherence to the American College of Surgeons (ACS) antibiotic prophylaxis recommendations and surgical site infections (SSIs)
The univariable associations are the percentage of each adherence group that experienced an SSI. The multivariable associations are odds ratios of the association between adherence and SSI, controlling for potential confounders, obtained from a logistic regression model
SSI: surgical site infection
| Recommendation | Univariable associations | Multivariable associations | ||||
| % SSI (n / total) | 95% CI | P-value | Odds ratio (95% CI) | P-value | ||
| Weight-based dosing | Adherent | 2.4 (51 / 2,093) | 1.8 – 3.1 | 0.33 | 0.75 | 0.26 |
| Non-adherent | 2.0 (80 / 3,961) | 1.6 – 2.5 | (0.45 – 1.25) | |||
| Administration prior to incision | Adherent | 2.2 (122 / 5,530) | 1.8 – 2.6 | 0.49 | 1.79 | 0.25 |
| Non-adherent | 1.7 (9 / 542) | 0.6 – 2.7 | (0.66 – 4.80) | |||
| Timing of administration | Adherent | 2.2 (112 / 5,193) | 1.8 – 2.6 | 1.00 | 1.12 | 0.77 |
| Non-adherent | 2.2 (19 / 879) | 1.2 – 3.1 | (0.51 – 2.46) | |||
| Redosing | Adherent | 2.1 (124 / 5,913) | 1.7 – 2.5 | 0.09 | 0.84 | 0.70 |
| Non-adherent | 4.4 (7 / 159) | 1.2 – 7.6 | (0.34 – 2.08) | |||
| All recommendations | Adherent | 2.4 (42 / 1,726) | 1.7 – 3.2 | 0.42 | 0.97 | 0.88 |
| Non-adherent | 2.1 (89 / 4,328) | 1.6 – 2.5 | (0.60 – 1.55) | |||
Risk factors associated with SSI*
*Assessed via a multivariable logistic regression analysis controlling for adherence to ACS recommendations
ACS: The American College of Surgeons; SSI: surgical site infection; ASA: The American Society of Anesthesiologists
| Variable | Odds ratio (95% CI) | P-value | |
| Age, years | 0.99 (0.94 – 1.04) | 0.65 | |
| Sex | Male | Reference | 0.74 |
| Female | 0.94 (0.66 – 1.35) | ||
| Race | American Indian or Alaska Native | Reference | |
| Asian | 1.87 (0.45 – 7.81) | 0.39 | |
| Black or African American | 0.44 (0.06 – 3.15) | 0.42 | |
| Native Hawaiian or other Pacific Islander | 2.69 (0.49 – 14.7) | 0.25 | |
| Unknown/not reported | 2.42 (0.61 – 9.61) | 0.21 | |
| White | 1.98 (0.53 – 7.44) | 0.31 | |
| Ethnicity | Not Hispanic | Reference | |
| Hispanic | 0.84 (0.49 – 1.43) | 0.52 | |
| Unknown | 0.23 (0.05 – 1.10) | 0.07 | |
| Weight, kg | 1.01 (0.996 – 1.02) | 0.24 | |
| Surgical specialty | Neurosurgery | Reference | |
| Orthopedic surgery | 0.68 (0.33 – 1.40) | 0.29 | |
| Otolaryngology | 1.26 (0.54 – 2.89) | 0.59 | |
| Plastic surgery | 0.80 (0.32 – 2.01) | 0.63 | |
| General surgery | 0.69 (0.34 – 1.40) | 0.31 | |
| Urology | 0.46 (0.16 – 1.32) | 0.15 | |
| Type of admission | Inpatient | Reference | |
| Outpatient | 0.89 (0.50 – 1.58) | 0.69 | |
| Case status | Elective | Reference | |
| Urgent | 1.89 (1.12 – 3.20) | 0.01 | |
| Emergent | 1.24 (0.64 – 2.40) | 0.53 | |
| Wound classification | Clean | Reference | |
| Clean/contaminated | 1.93 (1.05 – 3.54) | 0.03 | |
| Contaminated | 1.24 (0.36 – 4.24) | 0.73 | |
| Dirty/infected | 3.43 (1.49 – 7.89) | 0.004 | |
| ASA classification | 1 | Reference | |
| 2 | 2.23 (1.18 – 4.22) | 0.01 | |
| 3 | 4.15 (2.15 – 8.02) | <0.001 | |
| 4 | 5.79 (2.54 – 13.2) | <0.001 | |
| 5 | N/A | N/A | |
| None assigned | 18.0 (0.78 – 412) | 0.07 | |
| Surgery duration, minutes | 1.27 (1.16 – 1.38) | <0.001 | |